Lepodisiran is being developed by biotech giant Eli Lilly & Co. Here’s the tale of this new drug, how it could help millions, and how this furthers the “less-is-more” strategy that will make Lilly the “King of the Mountain” in biotech.
As tariffs hit, markets tremble. Stocks slide, volatility spikes, and investors scramble. It’s a pattern we’ve seen before — and it’s playing out again.
Several companies have delayed their upcoming initial public offerings or have been considering doing so as President Trump's aggressive tariffs continued to roil global financial markets. Examples include Klarna, StubHub, and Chime.
The big, overleveraged and overexposed investors, who held their positions over the past several weeks, are now trapped with huge losses after the recent market crash.
Mark Cuban is a billionaire and has shared many pieces of business advice over the years. One interview saw Cuban lay out four rules to becoming a millionaire.
SPX price is currently sitting below a confluence of two levels around 5130 and 5200. The next confluence levels lie from approximately 4500 to 4630 and 4800.
